Targeting Megalin for Delivery of Genetic Medicines to the Kidney
3:30 pm - Friday 29th January 2027
- Employing Megalin-mediated selective delivery of oligonucleotides to kidney proximal tubule epithelial cells
- Developing potent, durable, kidney-specific gene silencing with cell-type precision
- Exploring emerging applications for kidney and systemic diseases.
